PALMIERI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 15.196
AS - Asia 8.534
SA - Sud America 6.314
EU - Europa 3.973
AF - Africa 356
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 38
Totale 34.452
Nazione #
US - Stati Uniti d'America 14.841
BR - Brasile 5.668
SG - Singapore 4.332
CN - Cina 1.858
UA - Ucraina 1.327
HK - Hong Kong 857
DE - Germania 561
IT - Italia 467
SE - Svezia 419
VN - Vietnam 330
FI - Finlandia 306
AR - Argentina 194
GB - Regno Unito 179
FR - Francia 172
TR - Turchia 168
CA - Canada 136
MX - Messico 130
EC - Ecuador 127
BD - Bangladesh 122
RU - Federazione Russa 118
IQ - Iraq 116
ZA - Sudafrica 98
IN - India 95
MA - Marocco 85
VE - Venezuela 81
UZ - Uzbekistan 70
CO - Colombia 69
KR - Corea 67
AT - Austria 66
PL - Polonia 62
PK - Pakistan 56
JP - Giappone 55
PY - Paraguay 48
CL - Cile 47
JO - Giordania 47
ES - Italia 42
KE - Kenya 41
TN - Tunisia 41
AZ - Azerbaigian 39
BE - Belgio 39
ID - Indonesia 37
NL - Olanda 36
AE - Emirati Arabi Uniti 35
AU - Australia 35
UY - Uruguay 31
NP - Nepal 30
RO - Romania 28
EU - Europa 27
PE - Perù 27
AL - Albania 25
KZ - Kazakistan 25
OM - Oman 25
DZ - Algeria 24
LT - Lituania 23
CZ - Repubblica Ceca 22
BO - Bolivia 19
JM - Giamaica 19
EG - Egitto 18
LB - Libano 18
HN - Honduras 17
IL - Israele 17
IR - Iran 16
KG - Kirghizistan 16
RS - Serbia 16
DO - Repubblica Dominicana 15
SN - Senegal 15
SA - Arabia Saudita 13
BH - Bahrain 12
GE - Georgia 11
PA - Panama 10
AM - Armenia 9
PS - Palestinian Territory 9
CH - Svizzera 8
CI - Costa d'Avorio 8
SY - Repubblica araba siriana 8
XK - ???statistics.table.value.countryCode.XK??? 8
BG - Bulgaria 7
BY - Bielorussia 7
CR - Costa Rica 7
MN - Mongolia 7
NI - Nicaragua 7
A2 - ???statistics.table.value.countryCode.A2??? 6
KW - Kuwait 6
TT - Trinidad e Tobago 6
BN - Brunei Darussalam 5
GR - Grecia 5
LK - Sri Lanka 5
MD - Moldavia 5
NG - Nigeria 5
PH - Filippine 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
HU - Ungheria 4
IE - Irlanda 4
ET - Etiopia 3
GA - Gabon 3
GT - Guatemala 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
Totale 34.406
Città #
Dallas 6.108
Singapore 2.373
Chandler 2.350
Hong Kong 852
Princeton 768
Jacksonville 660
Ashburn 408
Beijing 385
São Paulo 385
Wilmington 286
Dearborn 276
Nanjing 262
Shanghai 247
Belo Horizonte 171
Rio de Janeiro 157
Ann Arbor 150
New York 148
Helsinki 139
Ho Chi Minh City 139
Los Angeles 135
Boardman 125
Santa Clara 120
Nanchang 112
Brasília 110
Sassari 106
Curitiba 81
Porto Alegre 81
Campinas 79
Columbus 74
The Dalles 74
Tianjin 70
Hanoi 68
Seoul 66
Shenyang 61
Tashkent 61
Nuremberg 60
San Francisco 57
Norwalk 55
Warsaw 55
Changsha 54
Guarulhos 54
Hebei 53
Tokyo 53
Jiaxing 51
Johannesburg 49
Toronto 47
Amman 46
Goiânia 46
Baghdad 45
Munich 42
Osasco 42
Ribeirão Preto 41
Salvador 40
Brussels 39
Guayaquil 39
Council Bluffs 38
Fortaleza 38
Santo André 38
Brooklyn 37
Buffalo 37
Nairobi 37
Dhaka 36
Mountain View 36
Falls Church 35
Istanbul 35
Manaus 35
Montreal 35
Vienna 35
Woodbridge 35
Caxias do Sul 33
Joinville 33
Quito 33
São Bernardo do Campo 33
Frankfurt am Main 32
Sorocaba 32
Ankara 31
Betim 31
Campo Grande 31
Kunming 31
Recife 31
Stockholm 31
Baku 30
Mexico City 30
Juiz de Fora 29
Pelotas 29
Orem 27
São José dos Campos 27
Uberlândia 27
Contagem 26
Falkenstein 26
Jinan 26
London 26
Cagliari 25
Chennai 25
Hangzhou 25
Montevideo 25
Anápolis 24
Asunción 24
Atlanta 24
Bogotá 24
Totale 20.043
Nome #
Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma 1.148
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 324
KRAS mutations in Non-Small Cell Lung Cancer: translational aspects, current therapies and challenges for future research 289
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 263
EGFR mutation detection in Whole Slide Images of non-small cell lung cancers using a two-stage deep transfer learning approach 242
Aspetti epidemiologici dei tumori maligni dell’ovaio nel Nord Sardegna nel periodo 1992-2001 232
Analysis of fanconi anemia genes in colorectal cancer 186
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 182
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 176
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 175
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 172
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 168
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 168
Epidemiology of thyroid cancer in an area of epidemic thyroid goiter 161
Breast cancer incidence and mortality in North Sardinia in the period 1992 - 2010 159
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 157
A novel candidate gene in human endometrial cancer at chromosome 10q26 156
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 152
CASC2a gene is down-regulated in endometrial cancer 152
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature 151
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 147
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 145
Breast Nodular Fasciitis: A Comprehensive Review 145
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1,440 Sardinian patients with lung adenocarcinoma. 142
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 139
Phenotype characterization of human melanoma cells resistant to dabrafenib 139
Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status 137
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study 136
Long non-coding RNA CASC2 in human cancer 131
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 131
Presence of Jaagsiekte sheep retrovirus in tissue sections from human bronchioloalveolar carcinoma depends on patients' geographical origin 129
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 128
Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series with Next-Generation Sequencing Mutation Analysis 127
Breast cancer incidence and mortality in North Sardinia in the period 1992–2010 125
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma 124
Molecular classification of patients with malignant melanoma for new therapeutic strategies 123
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 123
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 123
Fanconi genes may contribute to melanoma pathogenesis 123
Genetic Instability Markers in Cancer 121
Genetic alterations in main candidate genes during melanoma progression 120
Cytogenetic assessment of the involvement of a new locus at 9p21 in malignant melanoma 119
Colorectal cancer epidemiology in an area with a spontaneous screening program 119
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 119
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 119
Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art 119
Mutation analysis of mucosal and cutaneous melanomas during progression 118
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 117
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 114
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 112
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma - Identification of specific patterns of genetic alteration 112
Adjuvant treatment of malignant melanoma: where are we? 112
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy 112
2,2’-dihydroxy-3,3’-dimethoxy-5,5’-dimethyl-6,6’-dibromo-1,1’-biphenyl: preparation, resolution, structure and biological activity 111
Uterine perivascular epithelioid cell neoplasms (PEComas): Report of two cases and literature review 111
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma 111
Microsatellite and fish analysis in endometrial cancer: Assessment of specific patterns of genetic and cytogenetic alterations with their clinical correlations 110
Head and neck cancer epidemiology in North Sardinia, Italy. 110
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 109
BRAF mutations and dysregulation of the MAP kinase pathway associated to sinonasal mucosal melanomas 109
Adjuvant therapy of cutaneous melanoma 109
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 109
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality 108
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 108
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia 107
Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001 106
Epidemiology of malignant pleural mesothelioma in the province of Sassari (Sardinia, Italy). A population-based report 106
The effect of COVID-19 emergency in the management of melanoma in Italy 106
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma 105
Screening for founder mutations in BRCA1/2 tumor susceptibility genes among breast cancer families from North Sardinia 105
Human gene mutations gene symbol: BRCA2 small insertion in breast cancer 104
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predispositions 103
Assessment of microsatellite instability in benign nevi, dysplastic nevi, and primary melanomas along with their metastases 103
Indagini immunoistochimiche e biomolecolari per l’evidenziazione di retrovirus jsrv-correlati, in carcinomi bronchiolo-alveolari dell’uomo 103
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay 103
Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node 102
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 102
Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010 102
Actin-binding protein (ABP-280) filamin gene maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. 101
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells 101
Identification of different patterns of genetic alteration (a new minimal LOH region at chromosome 10q25-26 and genomic instability) in Sardinian patients with sporadic endometrial cancer and correlation with clinicopathological parameters 101
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer 101
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 100
Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma 99
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy 99
3-year treatment with recombinant interferon- as adjuvant therapy of cutaneous malignant melanoma. 98
Pancreatic cancer burden in North Sardinia, Italy 98
Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia 98
Screening for germline mutations of candidate genes in sardinian cancer families 98
Overexpression of h-prune in breast cancer is correlated with advanced disease status 97
Long Noncoding RNAs in Non-Small Cell Lung Cancer: State of the Art 97
Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma 97
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 96
Assessment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 95
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: report of two cases with molecular analysis 95
A Role ofBRCA1andBRCA2germline mutations in breast cancer susceptibility within Sardinian population 95
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases 94
Enhanced anti-tumor activity of a newcurcumin-related compound against melanoma and neuroblastoma cells 94
Primary melanoma of the lung: A systematic review 94
Colorectal cancer epidemiology in an area with a spontaneous screening program 94
Totale 13.767
Categoria #
all - tutte 155.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.373 0 0 0 0 0 84 249 4 402 439 116 79
2021/20221.591 150 8 7 28 21 35 81 129 144 130 171 687
2022/20234.418 431 204 76 818 370 874 2 493 803 36 187 124
2023/20241.088 260 119 29 36 125 81 26 109 3 19 93 188
2024/202511.568 93 83 657 213 405 510 489 2.503 4.350 1.556 427 282
2025/202611.558 465 5.038 2.153 2.074 1.574 254 0 0 0 0 0 0
Totale 34.926